Health Catalyst (HCAT) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts HCAT Hot Sheet
Join SI Premium – FREE
Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $76.32 million versus the consensus estimate of $75.9 million.
For earnings history and earnings-related data on Health Catalyst (HCAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rockstar Energy founder seeks CEO role at Celsius Holdings
- bioAffinity (BIAF) Tops Q2 EPS by 146c
- Citi Downgrades Legal & General Group PLC (LGEN:LN) (LGGNF) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
